Connect with us

Technologies

COVID raises risk of stillbirth, new research finds. What to know about vaccines during pregnancy

Here’s what we know about COVID-19 boosters, fertility and more.

For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.

In September, the US Centers for Disease Control and Prevention recommended «urgent action» be taken to get pregnant people, and those who want to be pregnant in the future, vaccinated against COVID-19. The alert was issued after mounting evidence demonstrated how COVID-19 affected the outcomes of pregnancy and the overall health of the pregnant person. As of mid-September, only 31% of pregnant people were vaccinated against COVID-19 — a much lower rate than the general US adult population — but they had a 70% increased risk of dying from symptomatic COVID-19 compared to people who weren’t pregnant.

Now, research is showing that pregnant people with COVID-19 have a higher risk of their baby being stillborn, according to a November report by the CDC. While the overall rate of stillbirths was low from March 2020 to September 2021, people who had COVID-19 during their delivery had a 1.26% chance of stillbirth, compared to people without COVID-19 at .64% — roughly double the risk. This risk was even higher, the CDC said, during the months the delta variant was circulating.

The CDC, along with other organizations that serve pregnant people such as the American College of Obstetrics and Gynecology and the Society for Maternal-Fetal Medicine have all issued recommendations that pregnant people get vaccinated against COVID-19. This is because research available during the pandemic shows that COVID-19 vaccines are safe for pregnant people, breastfeeding parents and people who may consider pregnancy in the future.

The World Health Organization says COVID-19 vaccines approved by the WHO (which include Pfizer, Moderna and Johnson & Johnson) can be taken by people who are on their period (menstruating), pregnant, planning to get pregnant and breastfeeding.

But advice for pregnant people trying to make decisions about vaccines hasn’t always been so strong. Pregnant people are often left out of medical studies, so when vaccines initially became available to protect against COVID-19, those who were pregnant were absent from the early studies on coronavirus shots. While the COVID-19 pandemic has shone some light on pregnant and breastfeeding people’s age-old status as «vulnerable,» the lack of data collected about pregnancy in the clinical trials of all three of the vaccines available in the US may have left you sifting through conflicting advice on how best to protect you and your child. As new data emerges and illustrates how pregnancy increases risk of COVID-19 disease for parents, which also puts their child at risk, here’s what we know about COVID-19 vaccines and boosters in pregnancy.

I’m pregnant. Should I get the COVID-19 vaccine?

The CDC made its official recommendation in August that, yes, pregnant people, breastfeeding people and those who want to be pregnant in the future should get a COVID-19 vaccine. The ACOG and SMFM also recommended COVID vaccines for pregnant people at the end of July after reports from «tens of thousands» demonstrated the safety of COVID-19 vaccines in pregnancy.

Other vaccines are recommended or offered during pregnancy. Some vaccines, for other diseases, aren’t recommended for pregnant people because they contain (very small amounts) of a live virus. None of the coronavirus vaccines available in the US use a live virus.

Do I need a booster if I’m fully vaccinated and pregnant?

Boosters are authorized for all adults in the US, including pregnant people (as long as you’re 18 years or older). You may get a shot at least six months after your second Pfizer or Moderna vaccine, or at least two months after your Johnson & Johnson shot, according to CDC guidance. You can get any COVID-19 vaccine available in the US as a booster if you prefer to switch brands for any reason.

Read more: How to choose a booster: What to know about mixing coronavirus vaccines

The CDC guidance for the general adult population leaves the decision on whether to boost up to the individual. However, pregnant people were actually eligible for boosters before the general public because pregnancy, or being recently pregnant, makes someone more susceptible to severe COVID-19. The ACOG, which gives guidance to pregnant individuals and their providers, recommends boosters for people who are fully vaccinated and pregnant or up to six weeks postpartum. The SMFM also recommends boosters for pregnant individuals at least six months after their second shot (or two months after, for people who received Johnson & Johnson’s vaccine).

What are the side effects of the vaccine for pregnant people?

Preliminary data on about 35,000 pregnant people who were vaccinated and volunteered information through the V-safe program shows that pregnant people have the same vaccine side effects as nonpregnant people — temporary injection pain in the arm, fatigue, headache, muscle aches and fever.

However, it’s important to note that fever from any cause has been associated with adverse pregnancy outcomes, and the CDC recommends pregnant people who experience fever after vaccination take acetaminophen to lower their body temperature.

Why are pregnant people at a high risk of COVID-19?

In May, CNET talked to Dr. Ella Speichinger, an OB-GYN at University of Missouri Health Care. She said it isn’t exactly known why pregnant people are at a higher risk, but that it may be because pregnant people’s immune systems are naturally depressed so their bodies don’t reject the growing fetus, or because pregnancy could alter the body’s way of mounting an immune response to COVID-19.

«I’ve had many patients who have had COVID while they were pregnant, and they’ve been just fine,» she said. «But there have definitely been severe cases where patients had to get delivered early because they could no longer oxygenate their fetus.»

In these cases, Speichinger said the patients usually improved after giving birth, but that it was delayed. It’s also impossible to know who will have a bad reaction to COVID-19 while pregnant.

«It’s really unclear who of the healthy pregnant cohorts is going to be the one that gets sick,» she said.

I’m skeptical of the vaccine. What are the risks of getting COVID-19 while pregnant?

Pregnant and recently pregnant people are at higher risk of severe illness from COVID-19, including death, according to the CDC, and they’re also at increased risk for preterm delivery (birth before 37 weeks) and other adverse pregnancy outcomes including stillbirth. Other health factors of the pregnant person, including a high BMI, diabetes or heart conditions, may elevate this risk, according to the SMFM.

Although there is information available now about how risky COVID-19 can be for pregnant people, that wasn’t necessarily the case at the beginning of the pandemic, and pregnant people were not highlighted specifically as «high risk.» Speichinger said that is likely because people who get pregnant are usually generally healthy and under age 40.

During what trimester should I get the vaccine?

Scientists who looked at people who got vaccinated earlier than 20 weeks pregnant didn’t find an increased risk of miscarriage compared to those who didn’t, according to a report from the V-safe pregnancy registry. Earlier data that was available reflected vaccination during the later stages of pregnancy.

Some people holding out on getting vaccinated during the first trimester may be due to the naturally high rate of miscarriage in the first three months, and patients being more cautious because of that. About 10% of known pregnancies end in miscarriage, according to the ACOG, but the risk also increases with age. About 80% of miscarriages happen in the first trimester.

«Most people feel concerned in the first trimester because there’s such a high risk of miscarriage in general,» Speichinger said. «Conflating the miscarriage with vaccine administration is what leads to vaccine hesitancy in the first trimester.»

Research shows that parents vaccinated during the third trimester of pregnancy may pass antibodies onto their newborns.

What if I’m breastfeeding?

«If a woman is uncomfortable doing it while pregnant, I absolutely think getting it while she’s breastfeeding is a good idea,» Speichinger said. «Because all of those antibodies can then cross through to the milk and protect baby while the mom is still producing those antibodies.»

There’s not enough data to show how long that protection lasts, but the CDC reports that breastfeeding people who have received an mRNA vaccine produce COVID-19 antibodies in their breast milk. In a small study on lactating health care workers who received a mRNA vaccine while breastfeeding, researchers from the University of Florida found that their breast milk had a «significant» amount of antibodies.

In its latest report, the CDC made a strong recommendation that breastfeeding people and those who were recently pregnant get a COVID-19 vaccine.

Does the vaccine type matter?

Moderna and Pfizer’s are mRNA vaccines, which use a new technology that delivers instructions to our immune systems on how to make protective proteins. Johnson & Johnson’s, the third vaccine available for emergency use in the US, uses viral vector technology by delivering a harmless virus into our bodies that triggers an immune response. Viral vector vaccines, notably the Ebola vaccine, have been studied in pregnant and breastfeeding people with no adverse effects found, according to the CDC.

The early research available now shows that mRNA vaccines are safe for pregnant women, and that miscarriage rates among women who received a COVID-19 vaccine are similar to miscarriage rates of women who didn’t get vaccinated. In a V-safe survey of 827 pregnant women who got a COVID-19 vaccine, about 14% experienced pregnancy loss — within the range that is naturally expected.

After the Food and Drug Administration lifted the pause that had been placed on Johnson & Johnson after reports of blood clots (the CDC identified 28 cases out of 8.7 million people vaccinated with Johnson & Johnson, the majority of them in women), the CDC issued a statement that women under age 50 should be aware of their increased risk of this still rare, but serious form of blood clots, and consider the other vaccines that don’t carry this risk. Given the demographic of the blood-clotting risk, Speichinger said her bias would steer her pregnant patients toward a Pfizer or Moderna vaccine.

«I still think the risk is exceedingly rare compared to the complications of COVID,» she said. «But if you had a choice, I would pick one of the other two.»

I want to be pregnant in the future. Will the COVID-19 vaccine make me infertile?

The fear people have regarding their fertility and vaccination isn’t exclusive to the COVID-19 vaccine. The specific fear about infertility and COVID-19 vaccines stems from a now-debunked post on Facebook that claimed the vaccine would make pregnant people’s bodies attack a protein needed for placenta formation in early pregnancy, because, it asserted, the spike protein in the COVID-19 vaccine is «similar.» Experts have disproved this, saying that not only do the two proteins have «almost nothing in common,» but even if they did, infection with COVID-19 would have the same outcome. There is no research to suggest people who have had COVID-19 will have a more difficult time getting pregnant, and many have since the beginning of the pandemic. If you’d like more information about COVID-19 vaccines and pregnancy, Dr. Danielle Jones, an OB-GYN who is also known as «Mama Doctor Jones» on TikTok, shared this video on YouTube debunking myths about COVID-19 vaccines and infertility, miscarriage and pregnancy.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Technologies

Google races to put Gemini at the center of Android before Apple’s AI reboot

Google is using its latest Android rollout to position Gemini as the AI layer across phones, Chrome, laptops and cars.

Google is using its latest Android rollout to make Gemini less of a chatbot and more of an operating layer across the phone, browser, car and laptop, just weeks before Apple is expected to show its own Gemini-powered Apple Intelligence reboot at WWDC.
Ahead of its Google I/O developer conference next week, the company previewed a number of Android updates, including AI-powered app automation, a smarter version of Chrome on Android, new tools for creators, a redesigned Android Auto experience, and a sweeping set of new security features.
Alphabet is counting on Gemini to help Google compete directly with OpenAI and Anthropic in the market for artificial intelligence models and services, while also serving as the AI backbone across its expansive portfolio of products, including Android. Meanwhile, Gemini is powering part of Apple’s new AI strategy, giving Google a role in the iPhone maker’s reset even as it races to prove its own version of personal AI on the phone is further along.
Sameer Samat, who oversees Google’s Android ecosystem, told CNBC that Google is rebuilding parts of Android around Gemini Intelligence to help users complete everyday tasks more easily.
“We’re transitioning from an operating system to an intelligence system,” he said.
As part of Tuesday’s announcements. Google said Gemini Intelligence will be able to move across apps, understand what’s on the screen and complete tasks that would normally require a user to jump between multiple services. That means Android is moving beyond the traditional assistant model, where users ask a question and get an answer, and acting more like an agent.
For instance, Google says Gemini can pull relevant information from Gmail, build shopping carts and book reservations. Samat gave the example of asking Gemini to look at the guest list for a barbecue, build a menu, add ingredients to an Instacart list and return for approval before checkout.
A big concern surrounding agentic AI involves software taking action on a user’s behalf without permissions. Samat said Gemini will come back to the user before completing a transaction, adding, “the human is always in the loop.”
Four months after announcing its Gemini deal with Google, Apple is under pressure to show a more capable version of Apple Intelligence, which has been a relative laggard on the market. Apple has long framed privacy, hardware integration and control of the user experience as its advantages.
Google’s Android push is designed to show it can bring AI deeper into the device experience while still giving users control over what Gemini can see, where it can act and when it needs confirmation.
The app automation features will roll out in waves, starting with the latest Samsung Galaxy and Google Pixel phones this summer, before expanding across more Android devices, including watches, cars, glasses and laptops later this year.
The company is also redesigning Android Auto around Gemini, turning the car into another major surface for its assistant. Android Auto is in more than 250 million cars, and Google says the new release includes its biggest maps update in a decade and Gemini-powered help with tasks like ordering dinner while driving.
Alphabet’s AI strategy has been embraced by Wall Street, which has pushed the company’s stock price up more than 140% in the past year, compared to Apple’s roughly 40% gain. Investors now want to see how Gemini can become more central to the products people use every day.
WATCH: Alphabet briefly tops Nvidia after report of $200 billion Anthropic cloud deal

Continue Reading

Technologies

Waymo recalls 3,800 robotaxis after glitch allowed some vehicles to ‘drive into standing water’

Waymo issued a voluntary recall of about 3,800 of its robotaxis to fix software issues that could allow them to drive into flooded roadways.

Waymo is recalling about 3,800 robotaxis in the U.S. to fix software issues that could allow them to “drive onto a flooded roadway,” according to a letter on the National Highway Traffic Safety Administration’s website.
The voluntary recall is for Waymo vehicles that use the company’s fifth and sixth generation automated driving systems (or ADS), the U.S. auto safety regulator said in the letter posted Tuesday.
Waymo autonomous vehicles in Austin, Texas, were seen on camera driving onto a flooded street and stalling, requiring other drivers to navigate around them. It’s the latest example of a safety-related issue for the Alphabet-owned AV unit that’s rapidly bolstering its fleet of vehicles and entering new U.S. markets.
Waymo has drawn criticism for its vehicles failing to yield to school buses in Austin, and for the performance of its vehicles during widespread power outages in San Francisco in December, when robotaxis halted in traffic, causing gridlock.
The company said in a statement on Tuesday that it’s “identified an area of improvement regarding untraversable flooded lanes specific to higher-speed roadways,” and opted to file a “voluntary software recall” with the NHTSA.
“Waymo provides over half a million trips every week in some of the most challenging driving environments across the U.S., and safety is our primary priority,” the company said.
Waymo added that it’s working on “additional software safeguards” and has put “mitigations” in place, limiting where its robotaxis operate during extreme weather, so that they avoid “areas where flash flooding might occur” in periods of intense rain.
WATCH: Waymo launches new autonomous system in Chinese-made vehicle

Continue Reading

Technologies

Qualcomm tumbles 13% as semiconductor stocks retreat from historic AI-fueled surge

Semiconductor equities reversed sharply after a broad AI-driven advance, with Qualcomm suffering its worst day since 2020 amid inflation concerns and rising oil prices.

Semiconductor stocks fell sharply on Tuesday, reversing course after an extensive rally that had expanded the artificial intelligence investment theme well past Nvidia and driven the industry to unprecedented levels.

Qualcomm plunged 13% and was on track for its steepest single-day decline since 2020. Intel shed 8%, while On Semiconductor and Skyworks Solutions each lost more than 6%. The iShares Semiconductor ETF, which benchmarks the overall sector, fell 5%.

The sell-off came after a key gauge of consumer prices came in above forecasts, and as conflict in Iran pushed crude oil higher—prompting investors to shift away from riskier assets.

The preceding advance had widened the AI opportunity set beyond longtime industry leader Nvidia, which for much of the past several years had largely carried the market to new peaks on its own.

Explosive appetite for central processing units, along with the graphics processing units that power large language models, has sent chipmakers to all-time highs.

Market participants are wagering that the shift from AI model training to autonomous agents will lift demand for additional AI hardware. Among the beneficiaries are memory chip producers, which are raising prices as supply remains tight.

Micron Technology slid 6%, and Sandisk cratered 8%. Sandisk’s stock has surged more than six times over since January.

Continue Reading

Trending

Copyright © Verum World Media